In-vitro Study of Multifunctional PLGA-SPION Nanoparticles Loaded with Gemcitabine as Radiosensitizer Used in Radiotherapy

被引：14
|
作者：
Hamzian, Nima [1 ]
Hashemi, Maryam [2 ]
Ghorbani, Mahdi [3 ]
Aledavood, Seyed Amir [4 ]
Ramezani, Mohammad [5 ,6 ]
Toossi, Mohammad Hossein Bahreyni [7 ]
机构：
[1] Shahid Sadoughi Univ Med Sci, Fac Med, Dept Med Phys, Yazd, Iran
[2] Mashhad Univ Med Sci, Nanotechnol Res Ctr, Inst Pharmaceut Technol, Mashhad, Razavi Khorasan, Iran
[3] Shahid Beheshti Univ Med Sci, Fac Med, Dept Biomed Engn & Med Phys, Tehran, Iran
[4] Mashhad Univ Med Sci, Canc Res Ctr, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Inst Pharmaceut Technol, Mashhad, Razavi Khorasan, Iran
[6] Mashhad Univ Med Sci, Dept Pharmaceut Biotechnol, Sch Pharm, Mashhad, Razavi Khorasan, Iran
[7] Mashhad Univ Med Sci, Med Phys Res Ctr, Fac Med, Mashhad, Razavi Khorasan, Iran
来源：
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2019年 / 18卷 / 04期
基金：
美国国家科学基金会;
关键词：
Multifunctional drug delivery system; SPION-PLGA; Gemcitabine; Radiotherapy; Radiosensitizer; CANCER-CELLS; DELIVERY; FE3O4; VIVO;
D O I：
10.22037/ijpr.2019.14050.12131
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This study aimed to modify the biological response of cells to ionizing radiation by combination therapy using radio-sensitizer agent and anticancer drug. Super paramagnetic iron oxide nanoparlicles (SPIONs) were prepared and used with gemcitabine (Gem). These two agents were encapsulated simultaneously intopoly (D, L-lactic-co-glycolic acid) (PLGA) to form multifunctional drug delivery system. The physicochemical characteristics of the nanoparticles (NPs) were studied. The dose enhancement ratio (DER) of various treatment groups was calculated and compared using human breast cancer cell line (MCF-7). The DER for PLGA-SPION-Gem was the highest at 1 Gy(60)Co (3.18). Cumulative effect from simultaneous use of two radiosensitizer (Gem and SPIONs) was observed. Thus, we have successfully developed PLGA NPs loaded with gemcitabine and SPIONas a radiosensitizersystem which potentially could be used in radiotherapy.
引用
收藏
页码：1694 / 1703
页数：10
相关论文
共 50 条
  • [21] Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice
    Liang, Qiuzhen
    Xiang, Haibin
    Li, Xinyu
    Luo, Chunxia
    Ma, Xuehong
    Zhao, Wenhui
    Chen, Jiangtao
    Tian, Zheng
    Li, Xinxia
    Song, Xinghua
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 7491 - 7507
  • [22] TurboBeads magnetic nanoparticles functionalized with gold as a promising nano-radiosensitizer for potential breast cancer radiotherapy: In vitro study
    Darwesh, Reem
    Aboushoushah, Samia Faisal
    Almarhabi, Sahar
    Aldahlawi, Alia M.
    Elbialy, Nihal S.
    INORGANIC CHEMISTRY COMMUNICATIONS, 2021, 123
  • [23] Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study
    Stella, Giulia
    Cova, Emanuela
    Inghilleri, Simona
    Piloni, Davide
    Colombo, Miriam
    Mrakic-Sposta, Simona
    Pandolfi, Laura
    Corsico, Angelo
    Pignochino, Ymera
    Prosperi, Davide
    Morbini, Patrizia
    Meloni, Federica
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [24] Effect of process variables on formulation, in-vitro characterisation and subcutaneous delivery of insulin PLGA nanoparticles: An optimisation study
    Abdelkader, Dalia H.
    El-Gizawy, Sanaa A.
    Faheem, Ahmed M.
    McCarron, Paul A.
    Osman, Mohamed A.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 43 : 160 - 171
  • [25] Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies
    Jamil, Adeeba
    Mirza, Mohd Aamir
    Anwer, Md Khalid
    Thakur, Pragya S.
    Alshahrani, Saad M.
    Alshetaili, Abdullah S.
    Telegaonkar, Sushama
    Panda, Amulya K.
    Iqbal, Zeenat
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (05) : 745 - 753
  • [26] Synthesis and appraisal of dalbergin-loaded PLGA nanoparticles modified with galactose against hepatocellular carcinoma: In-vitro, pharmacokinetic, and in-silico studies
    Gautam, Anurag Kumar
    Kumar, Pranesh
    Maity, Biswanath
    Routholla, Ganesh
    Ghosh, Balaram
    Chidambaram, Kumarappan
    Begum, M. Yasmin
    Al Fatease, Adel
    Rajinikanth, P. S.
    Singh, Sanjay
    Saha, Sudipta
    Vijayakumar, M. R.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] EpCAM aptamer activated 5-FU-loaded PLGA nanoparticles in CRC treatment; in vitro and in vivo study
    Yavari, Bahram
    Athari, Seyyed Shamsadin
    Omidi, Yadollah
    Jalali, Akram
    Najafi, Rezvan
    JOURNAL OF DRUG TARGETING, 2023, 31 (03) : 296 - 309
  • [28] Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats
    Anwer, Khalid
    Mohammad, Muqtader
    Ezzeldin, Essam
    Fatima, Farhat
    Alalaiwe, Ahmed
    Iqbal, Muzaffar
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 1587 - 1595
  • [29] In Vitro Study of PLGA/PFH Particles Loaded with Gold Nanoparticles as Theranostic Agents for Photoacoustic Imaging and Cancer Therapy
    Wang, Yan J.
    Strohm, Eric M.
    Kolios, Michael C.
    Sun, Yang
    Zheng, Yuanyi
    Wang, Zhigang
    2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), 2014, : 1658 - 1661
  • [30] Paclitaxel and spirulina co-loaded polymeric nanoparticles: in-vitro and in-vivo anticancer study
    Ravikumar, Yamuna
    Catherine, Dorcas Pinky
    Nair, Keerthi G. S.
    Sekar, Akshya
    Velmurugan, Ramaiyan
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 56
12345